Wen Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wen Zhang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Bangjiang Fang
Department of Emergency, LongHua Hospital, Shanghai University of Traditional Chinese Medicine
6 shared publications Jielian Luo
Department of Emergency, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
5 shared publicationsRunze Zhang
Department of Emergency, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
4 shared publicationsLiang Liu
Department of Emergency, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
3 shared publicationsChenming He
Department of Emergency, LongHua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
2 shared publicationsChenxing Huo
Department of Emergency, Longhua Hospital, Shanghai University of Traditional, Chinese Medicine, Shanghai, 200032, China
2 shared publications
Latest Publications
- Open Access
- 1 March 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-18
Global Trends of Cognition-Targeted Interventions in Chronic Lung Disease: A Bibliometric and Visualized Analysis
Purpose: To map the research landscape and synthesize randomized evidence on cognitive interventions for adults with chronic lung disease (CLD). Methods: This two-stage study involved: (i) bibliometric mapping of Web of Science Core Collection (WOSCC) (Jan 2005–May 2025) to evaluate output, collaboration, and thematic trends via VOSviewer, CiteSpace, and Bibliometrix; and (ii) narrative synthesis of Randomized Controlled Trials (RCTs) in adults (≥ 18 y) with chronic lung diseases and validated cognitive outcomes, identified from WOSCC, Scopus, and PubMed (to May 1, 2025). Screening, data extraction, and RoB 2 assessment were conducted in duplicate. Results: Bibliometric mapping (2005– 2025) of 3,474 publications showed sustained growth, broad international collaboration, and a shift from epidemiology to mechanisms and patient-centered outcomes. Fifteen RCTs, mostly in stable Chronic Obstructive Pulmonary Disease (COPD), assessed inspiratory-muscle/breathing training, aerobic-resistance or dance exercise, exercise with behavioral/educational components, multimodal cognitive-lifestyle programs, and pharmacological/nutritional or acute physiological therapies Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) were the most common cognitive measures, alongside executive-function tests. Methodological quality was generally moderate. Conclusion: Bibliometrics and randomized-trial synthesis reveal a rapidly growing, globally connected CLD-cognition field moving from epidemiology toward mechanistic and patient-centered research. Multimodal PR, especially exercise and inspiratory-muscle training, shows neurotherapeutic promise, but substantial gaps persist in Low and Middle Income Countries (LMICs) and non-COPD populations.
- 1 March 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-18
Open AccessGlobal Trends of Cognition-Targeted Interventions in Chronic Lung Disease: A Bibliometric and Visualized Analysis
Purpose: To map the research landscape and synthesize randomized evidence on cognitive interventions for adults with chronic lung disease (CLD). Methods: This two-stage study involved: (i) bibliometric mapping of Web of Science Core Collection (WOSCC) (Jan 2005–May 2025) to evaluate output, collaboration, and thematic trends via VOSviewer, CiteSpace, and Bibliometrix; and (ii) narrative synthesis of Randomized Controlled Trials (RCTs) in adults (≥ 18 y) with chronic lung diseases and validated cognitive outcomes, identified from WOSCC, Scopus, and PubMed (to May 1, 2025). Screening, data extraction, and RoB 2 assessment were conducted in duplicate. Results: Bibliometric mapping (2005– 2025) of 3,474 publications showed sustained growth, broad international collaboration, and a shift from epidemiology to mechanisms and patient-centered outcomes. Fifteen RCTs, mostly in stable Chronic Obstructive Pulmonary Disease (COPD), assessed inspiratory-muscle/breathing training, aerobic-resistance or dance exercise, exercise with behavioral/educational components, multimodal cognitive-lifestyle programs, and pharmacological/nutritional or acute physiological therapies Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) were the most common cognitive measures, alongside executive-function tests. Methodological quality was generally moderate. Conclusion: Bibliometrics and randomized-trial synthesis reveal a rapidly growing, globally connected CLD-cognition field moving from epidemiology toward mechanistic and patient-centered research. Multimodal PR, especially exercise and inspiratory-muscle training, shows neurotherapeutic promise, but substantial gaps persist in Low and Middle Income Countries (LMICs) and non-COPD populations.
- Open Access
- 23 October 2025
- Published by Elsevier in Neurotherapeutics
- Vol. 23 (1) , e00764
Risk factors for prolonged mechanical ventilation in critically ill patients with ischemic stroke
- 23 October 2025
- Published by Elsevier in Neurotherapeutics
- Vol. 23 (1) , e00764
Open AccessRisk factors for prolonged mechanical ventilation in critically ill patients with ischemic stroke
- 5 August 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 353 (Pt A) , 120300
Metabolomics-guided analysis combined with network pharmacology and molecular simulations reveals the mechanism of JHT in treating septic intestinal dysfunction
- 5 August 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 353 (Pt A) , 120300
Metabolomics-guided analysis combined with network pharmacology and molecular simulations reveals the mechanism of JHT in treating septic intestinal dysfunction
- Open Access
- 19 June 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1598443
Bibliometric analysis of sepsis and gut microbiota: Trends from 2014 to 2024
Background: Sepsis is a life-threatening condition characterized by organ dysfunction resulting from a dysregulated host response to infection, with pathological mechanisms closely linked to imbalances in the intestinal flora. While the gut microbiota influences sepsis progression through metabolic and immune regulation, systematic analyses of research trends remain limited. This bibliometric study comprehensively evaluates the sepsis and gut microbiota field from 2014 to 2024.Methods: We analyzed 944 English-language articles from the Web of Science (WOS) Core Collection using CiteSpace, VOSviewer, and other software tools. The bibliometric assessments included analysis of publication trends, collaborative networks, geographic distributions, journal impact, and keyword clustering.Results: A total of 944 publications included contributions from 5,901 authors across 69 countries. These works were published in 405 journals, and cited a total of 45,932 references. The focus of research has transitioned from early topics such as “necrotizing enterocolitis” and “premature infants” to more recent interests on “short-chain fatty acids” (SCFAs) and “Candida albicans.” Futhermore, emerging topics include “sepsis-associated encephalopathy,” with microbiology and critical care medicine identified as interdisciplinary core fields.Conclusion: The therapeutic potential of the gut microbiota in sepsis is increasingly recognized. Future research should prioritize microbial-targeted therapies, immune-barrier-metabolic network regulation, and integrated traditional Chinese–Western medicine approaches.
- 19 June 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1598443
Open AccessBibliometric analysis of sepsis and gut microbiota: Trends from 2014 to 2024
Background: Sepsis is a life-threatening condition characterized by organ dysfunction resulting from a dysregulated host response to infection, with pathological mechanisms closely linked to imbalances in the intestinal flora. While the gut microbiota influences sepsis progression through metabolic and immune regulation, systematic analyses of research trends remain limited. This bibliometric study comprehensively evaluates the sepsis and gut microbiota field from 2014 to 2024.Methods: We analyzed 944 English-language articles from the Web of Science (WOS) Core Collection using CiteSpace, VOSviewer, and other software tools. The bibliometric assessments included analysis of publication trends, collaborative networks, geographic distributions, journal impact, and keyword clustering.Results: A total of 944 publications included contributions from 5,901 authors across 69 countries. These works were published in 405 journals, and cited a total of 45,932 references. The focus of research has transitioned from early topics such as “necrotizing enterocolitis” and “premature infants” to more recent interests on “short-chain fatty acids” (SCFAs) and “Candida albicans.” Futhermore, emerging topics include “sepsis-associated encephalopathy,” with microbiology and critical care medicine identified as interdisciplinary core fields.Conclusion: The therapeutic potential of the gut microbiota in sepsis is increasingly recognized. Future research should prioritize microbial-targeted therapies, immune-barrier-metabolic network regulation, and integrated traditional Chinese–Western medicine approaches.
- Open Access
- 18 December 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1452276
Pathologic function and therapeutic potential of extracellular vesicle miRNA in sepsis
Sepsis is a systemic inflammatory response initiated by an infection, which can lead to multi-organ dysfunction. The pathophysiology of sepsis is complex, and treatment options are limited. Traditional antibiotic therapies have shown limitations, such as promoting the emergence of antibiotic-resistant bacteria and disrupting the natural microbiota. Consequently, there is a pressing need to explore diverse therapeutic approaches for sepsis management. Extracellular vesicles, which play a crucial role in cell-to-cell communication, are released by various cell types throughout the body and possess a membrane structure composed of a lipid bilayer. MicroRNAs may be encapsulated within these structures and can be selectively delivered to target recipient cells through the activation of cell surface receptors or via endocytosis and fusion, thereby modulating the biological functions of target cells. The article examines the pathological alterations that happen as sepsis progresses and the biological control of extracellular vesicles and microRNAs in sepsis. This review focuses on the role of extracellular vesicles and their microRNAs on controlling the inflammatory response, macrophage polarization, programmed cell death, endothelial dysfunction, and microcirculatory changes in sepsis. Furthermore, the obstacles encountered by this novel therapy are also examined.
- 18 December 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1452276
Open AccessPathologic function and therapeutic potential of extracellular vesicle miRNA in sepsis
Sepsis is a systemic inflammatory response initiated by an infection, which can lead to multi-organ dysfunction. The pathophysiology of sepsis is complex, and treatment options are limited. Traditional antibiotic therapies have shown limitations, such as promoting the emergence of antibiotic-resistant bacteria and disrupting the natural microbiota. Consequently, there is a pressing need to explore diverse therapeutic approaches for sepsis management. Extracellular vesicles, which play a crucial role in cell-to-cell communication, are released by various cell types throughout the body and possess a membrane structure composed of a lipid bilayer. MicroRNAs may be encapsulated within these structures and can be selectively delivered to target recipient cells through the activation of cell surface receptors or via endocytosis and fusion, thereby modulating the biological functions of target cells. The article examines the pathological alterations that happen as sepsis progresses and the biological control of extracellular vesicles and microRNAs in sepsis. This review focuses on the role of extracellular vesicles and their microRNAs on controlling the inflammatory response, macrophage polarization, programmed cell death, endothelial dysfunction, and microcirculatory changes in sepsis. Furthermore, the obstacles encountered by this novel therapy are also examined.
- Open Access
- 9 June 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (23) , e33881
Predictive value of risk factors for prognosis of patients with sepsis in intensive care unit
Sepsis has emerged as a major global public health concern due to its elevated mortality and high cost of care. This study aimed to evaluate the risk factors associated with the mortality of sepsis patients in the Intensive Care Unit (ICU), and to intervene in the early stages of sepsis in order to improve patient outcomes and reduce mortality. From January 1st, 2021 to December 31st, 2021, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Huashan Hospital Affiliated to Fudan University, and The Seventh People’s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine were designated as sentinel hospitals, and sepsis patients in their respective ICU and Emergency ICU were selected as research subjects, and divided into survivors and non-survivors according to their discharge outcomes. The mortality risk of sepsis patients was subsequently analyzed by logistic regression. A total of 176 patients with sepsis were included, of which 130 (73.9%) were survivors and 46 (26.1%) were non-survivors. Factors identified as having an impact on death among sepsis patients included female [Odds Ratio (OR) = 5.135, 95% confidence interval (CI): 1.709, 15.427, P = .004)], cardiovascular disease (OR = 6.272, 95% CI: 1.828, 21.518, P = .004), cerebrovascular disease (OR = 3.133, 95% CI: 1.093, 8.981, P = .034), pulmonary infections (OR = 6.700, 95% CI: 1.744, 25.748, P = .006), use of vasopressors (OR = 34.085, 95% CI: 10.452, 111.155, P < .001), WBC < 3.5 × 109/L (OR = 9.752, 95% CI: 1.386, 68.620, P = .022), ALT < 7 U/L (OR = 7.672, 95% CI: 1.263, 46.594, P = .027), ALT > 40 U/L (OR = 3.343, 95% CI: 1.097, 10.185, P = .034). Gender, cardiovascular disease, cerebrovascular disease, pulmonary infections, the use of vasopressors, WBC, and ALT are important factors in evaluating the prognostic outcome of sepsis patients in the ICU. This suggests that medical professionals should recognize them expeditiously and implement aggressive treatment tactics to diminish the mortality rate and improve outcomes.
- 9 June 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (23) , e33881
Open AccessPredictive value of risk factors for prognosis of patients with sepsis in intensive care unit
Sepsis has emerged as a major global public health concern due to its elevated mortality and high cost of care. This study aimed to evaluate the risk factors associated with the mortality of sepsis patients in the Intensive Care Unit (ICU), and to intervene in the early stages of sepsis in order to improve patient outcomes and reduce mortality. From January 1st, 2021 to December 31st, 2021, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Huashan Hospital Affiliated to Fudan University, and The Seventh People’s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine were designated as sentinel hospitals, and sepsis patients in their respective ICU and Emergency ICU were selected as research subjects, and divided into survivors and non-survivors according to their discharge outcomes. The mortality risk of sepsis patients was subsequently analyzed by logistic regression. A total of 176 patients with sepsis were included, of which 130 (73.9%) were survivors and 46 (26.1%) were non-survivors. Factors identified as having an impact on death among sepsis patients included female [Odds Ratio (OR) = 5.135, 95% confidence interval (CI): 1.709, 15.427, P = .004)], cardiovascular disease (OR = 6.272, 95% CI: 1.828, 21.518, P = .004), cerebrovascular disease (OR = 3.133, 95% CI: 1.093, 8.981, P = .034), pulmonary infections (OR = 6.700, 95% CI: 1.744, 25.748, P = .006), use of vasopressors (OR = 34.085, 95% CI: 10.452, 111.155, P < .001), WBC < 3.5 × 109/L (OR = 9.752, 95% CI: 1.386, 68.620, P = .022), ALT < 7 U/L (OR = 7.672, 95% CI: 1.263, 46.594, P = .027), ALT > 40 U/L (OR = 3.343, 95% CI: 1.097, 10.185, P = .034). Gender, cardiovascular disease, cerebrovascular disease, pulmonary infections, the use of vasopressors, WBC, and ALT are important factors in evaluating the prognostic outcome of sepsis patients in the ICU. This suggests that medical professionals should recognize them expeditiously and implement aggressive treatment tactics to diminish the mortality rate and improve outcomes.